Congresso da EAACI 2024: Inovação e Avanços no Tratamento da Alergia
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Durante o congresso serão apresentadas mais de 150 sessões científicas, centradas nos avanços da ciência ambiental, alergias alimentares, inovações em imunoterapia e alergias pediátricas, entre...
Kongres EAACI 2024: Inovasi dan Kemajuan dalam Rawatan Alahan
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Lebih 150 sesi saintifik akan dibentangkan semasa kongres itu, yang antara lainnya memfokuskan kepada kemajuan dalam sains alam sekitar, alahan makanan, inovasi dalam imunoterapi dan alahan...
2024년도 EAACI 학술대회: 알레르기 치료의 혁신과 발전
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
학술대회 일환으로 환경 과학, 식품 알레르기, 면역 치료 혁신, 소아 알레르기 등의 주제에 초점 맞춘 150개 이상의 과학 세션 열릴 예정최대 규모의 알레르기 및 면역학 학술대회에서 다뤄질 정밀 의학, AI, 면역 치료, 면역 조절제5월 31일부터 6월 3일까지 스페인 발렌시아에서 개최 스페인 발렌시아, April 30, 2024 (GLOBE...
欧州アレルギー・臨床免疫学会2024 (EAACI Congress 2024)：アレルギー治療の革新と進歩
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
学会中は、環境科学の進歩、食物アレルギー、免疫療法の革新、小児アレルギーなどに焦点を当てた、150を超える科学セッションが開催される。精密医療、AI、免疫療法、免疫調節剤が、最大規模のアレルギーおよび免疫学学会に集結。同学会は、5月31日から6月3日までスペインのバレンシアで開催される。 スペイン、バレンシア発, April 30, 2024 (GLOBE NEWSWIRE) --...
Kongres EAACI 2024: Inovasi dan Kemajuan dalam Pengobatan Alergi
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Lebih dari 150 sesi ilmiah akan dipresentasikan selama pelaksanaan kongres, dengan fokus di berbagai bidang yang di antaranya mencakup kemajuan dalam sains lingkungan, alergi makanan, inovasi...
Congrès EAACI 2024 : innovations et progrès dans le traitement des allergies
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Lors de ce congrès, plus de 150 sessions scientifiques seront présentées. Les sujets abordés se concentreront sur les progrès de la science environnementale, les allergies alimentaires, les...
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
April 25, 2024 07:00 ET
|
Purple Biotech Ltd.
Interim data suggests reduced risk of progression or death in the CM24/nivolumab plus standard of care Nal-IRI/5FU/LV arm of the study REHOVOT, Israel, April 25, 2024 (GLOBE NEWSWIRE) --...
International Surrealism Now Exhibition Set to Open in Portugal
February 06, 2024 10:00 ET
|
International Surrealism
Mafra, Portugal, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The much-anticipated "International Surrealism Now" exhibition is set to open its doors from February 5th to 17th, 2024, at the historic Palácio de...
Holaluz cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023
January 31, 2024 03:52 ET
|
Holaluz Clidom SA
Barcelona, 31 de enero de 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023 Holaluz duplica su cuota de mercado...
Holaluz delivers on Normalised EBITDA guidance, reaching 3M€ for FY2023
January 31, 2024 03:52 ET
|
Holaluz Clidom SA
Barcelona, January 31, 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) delivers on Normalised EBITDA guidance, reaching 3M€ for FY2023 Holaluz doubled its solar market share in 2023...